Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): Results from the prodrome trial

被引：0

作者：

Goadsby, Peter ^{[1
]}

Ailani, Jessica ^{[2
]}

Dodick, David ^{[3
]}

Starling, Amaal ^{[3
]}

Davidovic, Goran ^{[4
]}

Liu, Chengcheng ^{[5
]}

Yun, Yu Sung ^{[5
]}

Brand-Schieber, Elimor ^{[5
]}

Finnegan, Michelle ^{[5
]}

Trugman, Joel ^{[5
]}

机构：

[1] Kings Coll London, Wellcome Fdn Bldg, London, England

[2] Georgetown Univ Hosp, Pasquerilla Healthcare Ctr, Neurol, Washington, DC 20007 USA

[3] Mayo Clin, Nerol, Scottsdale, AZ USA

[4] AbbVie, Neurosci, St Laurent, PQ, Canada

[5] AbbVie, Neurocience, Madison, NJ USA

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2023年 / 455卷

关键词：

D O I：

10.1016/j.jns.2023.121630

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

121630

引用

页数：1

共 50 条

[1] Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial
Goadsby, Peter J.
Ailani, Jessica
Dodick, David W.
Starling, Amaal J.
Liu, Chengcheng
Yu, Sung Yun
Brand-Schieber, Elimor
Finnegan, Michelle
Trugman, Joel M.
[J]. NEUROLOGY, 2023, 100 (17)
[2] Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): results from the PRODROME trial
Goadsby, P. J.
Ailani, J.
Dodick, D. W.
Starling, A. J.
Liu, C.
Yu, S. Y.
Brand-Schieber, E.
Finnegan, M.
Trugman, J. M.
[J]. JOURNAL OF HEADACHE AND PAIN, 2024, 25
[3] Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial
Goadsby, P.
Ailani, J.
Dodick, D.
Starling, A.
Liu, C.
Yu, S.
Brand-Schieber, E.
Finnegan, M.
Trugman, J.
[J]. HEADACHE, 2023, 63 : 137 - 137
[4] Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial
Lipton, Richard B.
Harriott, Andrea
Ma, Julia
Smith, Jonathan H.
Severt, Lawrence
Stokes, Jonathan
Gandhi, Pranav
Parikh, Krutika
Trugman, Joel M.
Dodick, David W.
[J]. NEUROLOGY, 2023, 100 (17)
[5] Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial
Lipton, Richard B.
Harriott, Andrea
Ma, Julia
Smith, Jonathan H.
Severt, Lawrence
Stokes, Jonathan
Gandhi, Pranav
Parikh, Krutika
Trugman, Joel M.
Dodick, David W.
[J]. CEPHALALGIA, 2023, 43 (1supp) : 62 - 63
[6] Improvement in Patient- Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial
Lipton, R.
Harriott, A.
Ma, J.
Smith, J.
Severt, L.
Stokes, J.
Gandhi, P.
Parikh, K.
Trugman, J.
Dodick, D.
[J]. HEADACHE, 2023, 63 : 142 - 143
[7] Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period
Schwedt, Todd J.
Lipton, Richard B.
Goadsby, Peter J.
Chiang, Chia-Chun
Klein, Brad
Liu, Chengcheng
Yu, Sung Yun
Severt, Lawrence
Finnegan, Michelle
Trugman, Joel M.
[J]. NEUROLOGY, 2023, 100 (17)
[8] Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period
Schwedt, T.
Lipton, R.
Goadsby, P.
Chiang, C.
Klein, B.
Liu, C.
Yu, S.
Severt, L.
Finnegan, M.
Trugman, J.
[J]. HEADACHE, 2023, 63 : 119 - 119
[9] Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study
Dodick, D.
Goadsby, P.
Schwedt, T.
Lipton, R.
Liu, C.
Lu, K.
Yu, S.
Severt, L.
Finnegan, M.
Trugman, J.
[J]. HEADACHE, 2023, 63 : 177 - 177
[10] Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study
Dodick, David W.
Goadsby, Peter J.
Schwedt, Todd J.
Lipton, Richard B.
Liu, Chengcheng
Lu, Kaifeng
Yu, Sung Yun
Severt, Lawrence
Finnegan, Michelle
Trugman, Joel M.
[J]. NEUROLOGY, 2023, 100 (17)

← 1 2 3 4 5 →